Phenotypic screening approaches for Chagas disease drug discovery.

Abstract excerpt

INTRODUCTION: Chagas disease, caused by the parasite Trypanosoma cruzi, is a global public health issue. Current treatments targeting the parasite are limited to two old nitroheterocyclic drugs with serious side effects. The need for new and safer drugs has prompted numerous drug discovery efforts to identify compounds suitable for parasitological cure in the last decade. Areas covered: Target-based drug...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chagas Disease
• Share to Drug Design
• Share to Drug Discovery